Archive · 13 Dec 2025
Acne Drug Shows Promise for Hair Loss
Scientists have found that a drug used to treat acne might also help men who are losing their hair.
This drug, called clascoterone, was tested on nearly 1,500 men and showed really good results in helping hair grow back.
The drug works by blocking a hormone that causes hair loss.
It's applied directly to the scalp, which makes it safer than some other treatments.
The trials showed that the drug is safe and doesn't have bad side effects.
If the drug gets approved by the FDA next year, it could be a big help for men who are losing their hair.
However, it's important to note that the drug's effectiveness depends on how much hair a person has left, and more studies are needed to see if it works well over a long time.
Clascoterone, an acne drug, shows significant promise in treating male pattern baldness.
Phase III trials with nearly 1,500 men showed a 539% improvement in hair restoration.
The drug is topical, applied to the scalp, and has no observed adverse effects.
Clascoterone blocks the hormone DHT, which causes hair follicles to shrink.
Potential FDA approval could come as early as next year, marking a major advance in hair-loss therapy.
- Who
- Men with male pattern baldness (androgenic alopecia)
- What
- Clascoterone, an acne drug, shows promise in treating hair loss
- When
- Phase III trials completed, potential FDA approval next year
- Where
- Trials conducted with nearly 1,500 men
- Why
- Clascoterone blocks the hormone DHT, which causes hair follicles to shrink, leading to baldness
- Drug Name
- Clascoterone
- Condition Treated
- Male Pattern Baldness (Androgenic Alopecia)
- Approval Status
- Approved for acne, in trials for hair loss
- Trial Results
- 539% improvement in hair restoration in Phase III trials
- Safety
- No adverse effects observed in trials
- Application
- Topical (applied to scalp)
- Potential Approval
- Possible FDA approval next year
- Stages of Baldness
- Seven stages from slight thinning to complete baldness